Fundraising in Europe vs. the US: What Nobody Tells You

European venture capital has matured enormously over the past decade. Total VC investment in Europe surpassed €100 billion in recent years, and the ecosystem now boasts dozens of funds capable of writing eight-figure checks. But if you've spent any time fundraising on both sides of the Atlantic, you know the process feels completely different.

American VCs optimize for speed and conviction. The best US funds will move from first meeting to term sheet in two weeks. European investors, with some notable exceptions, tend to move more deliberately. Due diligence is deeper, partnership decisions take longer, and the cultural expectation is that founders will have more answers, earlier.

This isn't a criticism — it's a reflection of different market dynamics. Understanding these differences is the first step to raising efficiently in Europe.

The most significant difference is round size and the implied expectations that come with it. European seed rounds are typically 30-50% smaller than US equivalents. A strong European seed might be €2-4M, compared to $4-8M in the US.

The downstream effect is that European VCs expect founders to reach meaningful revenue milestones with less capital. Where a US Series A might require $1M ARR as a benchmark, European Series A investors increasingly want to see €1.5-2M ARR — with a capital base that was often half the size.

This creates a discipline advantage for European founders who can operate lean, but it also means your financial model needs to be credible and detailed from the earliest stages. Hand-waving about TAM and showing a hockey-stick projection won't cut it. European investors will scrutinize your unit economics, cohort data, and cash efficiency at the seed stage in ways that US investors typically reserve for Series B conversations.

European term sheets tend to include more investor-protective provisions than their US counterparts. Liquidation preferences, anti-dilution clauses, and board composition terms are all areas where European and US norms diverge.

A few specifics to watch for:

Liquidation preferences: Participating preferred is more common in Europe than in the US, where non-participating preferred has become the default at early stages. Understand the difference — participating preferred can significantly reduce founder returns in moderate exit scenarios.

Board seats: European investors often expect board representation earlier. It's common for a seed investor to request a board seat or observer seat in Europe, whereas many US seed funds are content with information rights.

Vesting schedules: The four-year vest with a one-year cliff is standard everywhere, but European investors sometimes push for reverse vesting on existing shares rather than fresh option grants, particularly for solo founders. Negotiate this carefully.

Get a lawyer who has done deals in both markets. The nuances matter enormously at exit, and many founders don't realize the implications of their term sheet until it's too late to renegotiate.

Europe has a more established culture of bridge rounds and extensions than the US. This is partly a function of smaller initial rounds — founders run out of runway faster and need interim financing more frequently.

The good news is that European investors are generally more receptive to bridge rounds than US investors, who often view them as a signal of distress. In Europe, a well-structured bridge from existing investors is seen as a vote of confidence, not a red flag.

However, bridge rounds come with risks. They often include valuation caps or discount terms that dilute founders more than a priced round would. And they can create a "bridge to nowhere" scenario where the company raises successive bridges without ever achieving the metrics needed for a proper next round.

The best approach: if you need a bridge, structure it with a clear milestone plan and a defined timeline to the next priced round. Communicate openly with your existing investors about what you need to achieve and by when.

Despite the differences, raising in Europe has real advantages. The ecosystem is less competitive for attention — a strong founder with solid metrics will get meetings more easily than in the Bay Area, where top VCs are drowning in deal flow.

European investors also tend to be more patient capital partners. The cultural expectation of hyper-growth at all costs is less pronounced, and many European VCs are genuinely supportive of sustainable growth strategies. This can be a significant advantage if your business model requires longer sales cycles or higher upfront investment in product.

The smartest founders I work with raise a blended round — anchored by a European lead with strong local value-add, complemented by a US fund that brings network access and brand credibility for future rounds. This gives you the best of both worlds: patient capital, deep local support, and a warm introduction to the US ecosystem when you're ready to expand.

The key insight: don't try to run a US fundraising process in Europe. Adapt your timeline, your materials, and your expectations. The capital is here — you just need to speak its language.